Axogen (AXGN) Debt Ratio (2010 - 2025)
Axogen's quarterly Debt Ratio came in at 0.22 in Q4 2025, down 6.38% year-on-year from 0.23 in Q4 2024, and down 1.93% quarter-over-quarter from 0.22 in Q3 2025.
Axogen has reported Debt Ratio for 16 years, with the latest figure at 0.22 in Q4 2025.
- For the quarter ending Q4 2025, Debt Ratio fell 6.38% year-over-year to 0.22; the trailing twelve-month figure through Dec 2025 stood at 0.22 (down 6.38% YoY), and the FY2025 full-year result was 0.22, down 6.38% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.22, down from 0.22 in the prior quarter.
- The five-year high for Debt Ratio was 0.25 in Q1 2024, with the low at 0.16 in Q1 2021.
- Average Debt Ratio over 5 years is 0.23, with a median of 0.23 recorded in 2024.
- Year-over-year, Debt Ratio soared 693.31% in 2021 and dropped 9.61% in 2025.
- Tracing AXGN's Debt Ratio over 5 years: stood at 0.22 in 2021, then climbed by 8.58% to 0.23 in 2022, then gained by 1.2% to 0.24 in 2023, then decreased by 1.54% to 0.23 in 2024, then decreased by 6.38% to 0.22 in 2025.
- The last three Debt Ratio figures came in at 0.22 (Q4 2025), 0.22 (Q3 2025), and 0.23 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | 0.24 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.24 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.23 |
| Jun 30, 2022 | 0.23 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | 0.22 |
| Jun 30, 2021 | 0.22 |
| Mar 31, 2021 | 0.16 |
| Dec 31, 2020 | 0.16 |
| Sep 30, 2020 | 0.11 |
| Mar 31, 2020 | 0.02 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.02 |
| Jun 30, 2019 | 0.03 |
| Mar 31, 2019 | 0.03 |
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.39 |
| Dec 31, 2017 | 0.35 |
| Sep 30, 2017 | 0.58 |
| Jun 30, 2017 | 0.56 |
| Mar 31, 2017 | 0.56 |
| Dec 31, 2016 | 0.44 |
| Sep 30, 2016 | 0.81 |
| Jun 30, 2016 | 0.79 |
| Mar 31, 2016 | 0.74 |
| Dec 31, 2015 | 0.67 |
| Sep 30, 2015 | 0.62 |
| Jun 30, 2015 | 1.00 |
| Mar 31, 2015 | 0.90 |
| Dec 31, 2014 | 1.53 |
| Sep 30, 2014 | 1.40 |
| Jun 30, 2014 | 1.22 |
| Mar 31, 2014 | 1.07 |
| Dec 31, 2013 | 0.92 |
| Sep 30, 2013 | 0.82 |
| Jun 30, 2013 | 1.49 |
| Mar 31, 2013 | 1.26 |
| Dec 31, 2012 | 1.07 |
| Sep 30, 2012 | 0.29 |
| Jun 30, 2012 | 0.49 |
| Mar 31, 2012 | 0.46 |
| Dec 31, 2011 | 0.39 |
| Sep 30, 2011 | 0.33 |
| Dec 31, 2010 | 1.11 |